Researchers have developed a novel engineering strategy to overcome the common tendency of lipid nanoparticles (LNPs) to accumulate in the liver rather than other organs. By utilizing passive targeting through abdominal injection, the study found that larger particles—roughly 300 nanometres in diameter—selectively infiltrate the pancreas due to its uniquely thin protective capsule. To ensure effec...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动